help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labrie, F.
Right arrow Articles by Candas, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labrie, F.
Right arrow Articles by Candas, B.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 8 2403-2409
Copyright © 1997 by The Endocrine Society


Reproductive Endocrinology

Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology

Fernand Labrie, Alain Bélanger, Lionel Cusan and Bernard Candas

Medical Research Council Group in Molecular Endocrinology, Centre Hospitalier de l’Universite Laval Research Center, Le Centre Hospitalier Universitaire de Québec, and Laval University, Québec, G1V 4G2, Canada

Address all correspondence and requests for reprints to: Fernand Labrie, Laboratory of Molecular Endocrinology, CHUL Research Center, 2705 Laurier Boulevard, Québec, QC, G1V 4G2, Canada.

This study analyzes in detail the serum concentration of the active androgens and estrogens, as well as a series of free and conjugated forms of their precursors and metabolites, after daily application for 2 weeks of 10 mL 20% dehydroepiandrosterone (DHEA) solution on the skin to avoid first passage through the liver. In men, DHEA administration caused 175%, 90%, 200% and 120% increases in the circulating levels of DHEA and its sulfate (DHEA-S), DHEA-fatty acid esters, and androst-5-ene-3ß,17ß-diol, respectively, with a return to basal values 7 days after cessation of the 14-day treatment. Serum androstenedione increased by approximately 80%, whereas serum testosterone and dihydrotestosterone (DHT) remained unchanged. In parallel with the changes in serum DHEA, the concentrations of the conjugated metabolites of DHT, namely androsterone glucuronide, androstane-3{alpha},17ß-diol-G, and androstane-3ß,17ß-diol-G increased by about 75%, 50%, and 75%, respectively, whereas androsterone-sulfate increased 115%. No consistent change was observed in serum estrone (E1) or estradiol (E2) in men receiving DHEA, whereas serum E1-sulfate and E2-sulfate were slightly and inconsistently increased by about 20%, and serum cortisol and aldosterone concentrations were unaffected by DHEA administration. Almost superimposable results were obtained in women for most steroids except testosterone, which was about 50% increased during DHEA treatment. This increase corresponded to about 0.8 nM testosterone, an effect undetectable in men because they already have much higher (~15 nM) basal testosterone levels. In women, the serum levels of the conjugated metabolites of DHT, namely androsterone glucuronide, androstane-3{alpha},17ß-diol-G, androstane-3ß,17ß-diol-G, and androsterone-sulfate were increased by 125%, 140%, 120% and 150%, respectively. The present study demonstrates that the serum concentrations of testosterone, DHT, E1, and E2 are poor indicators of total androgenic and estrogenic activity. However, the esterified metabolites of DHT appear as reliable markers of the total androgen pool, because they directly reflect the intracrine formation of androgens in the tissues possessing the steroidogenic enzymes required to transform the inactive precursors DHEA and DHEA-S into DHT. As well demonstrated in women, who synthesize almost all their androgens from DHEA and DHEA-S, supplementation with physiological amounts of exogeneous DHEA permits the biosynthesis of androgens limited to the appropriate target tissues without leakage of significant amounts of active androgens into the circulation. This local or intracrine biosynthesis and action of androgens eliminates the inappropriate exposure of other tissues to androgens and thus minimizes the risks of undesirable masculinizing or other androgen-related side effects of DHEA.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. Vandenput, D. Mellstrom, M. Lorentzon, C. Swanson, M. K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, et al.
Androgens and Glucuronidated Androgen Metabolites Are Associated with Metabolic Risk Factors in Men
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4130 - 4137.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Swanson, M. Lorentzon, L. Vandenput, F. Labrie, A. Rane, J. Jakobsson, S. Chouinard, A. Belanger, and C. Ohlsson
Sex Steroid Levels and Cortical Bone Size in Young Men Are Associated with a Uridine Diphosphate Glucuronosyltransferase 2B7 Polymorphism (H268Y)
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3697 - 3704.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. Panjari and S. R. Davis
DHEA therapy for women: effect on sexual function and wellbeing
Hum. Reprod. Update, May 1, 2007; 13(3): 239 - 248.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
C. R. Gracia, E. W. Freeman, M. D. Sammel, H. Lin, and M. Mogul
Hormones and Sexuality During Transition to Menopause
Obstet. Gynecol., April 1, 2007; 109(4): 831 - 840.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. M. Pino, J. M. Rodriguez, S. Rios, P. Astudillo, L. Leiva, G. Seitz, M. Fernandez, and J P. Rodriguez
Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin
J. Endocrinol., December 1, 2006; 191(3): 715 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Basaria and A. S. Dobs
Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Caron, B. Cariou, and B. Staels
FXR: More than a Bile Acid Receptor?
Endocrinology, September 1, 2006; 147(9): 4022 - 4024.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. M. Jankowski, W. S. Gozansky, R. S. Schwartz, D. J. Dahl, J. M. Kittelson, S. M. Scott, R. E. Van Pelt, and W. M. Kohrt
Effects of Dehydroepiandrosterone Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2986 - 2993.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
F Labrie
Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
V Rochira, A Balestrieri, B Madeo, L Zirilli, A R M Granata, and C Carani
Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology
Eur. J. Endocrinol., February 1, 2006; 154(2): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie
Is dehydroepiandrosterone a hormone?
J. Endocrinol., November 1, 2005; 187(2): 169 - 196.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. R. Davis, S. L. Davison, S. Donath, and R. J. Bell
Circulating Androgen Levels and Self-reported Sexual Function in Women
JAMA, July 6, 2005; 294(1): 91 - 96.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. J. Schmidt, R. C. Daly, M. Bloch, M. J. Smith, M. A. Danaceau, L. Simpson St. Clair, J. H. Murphy, N. Haq, and D. R. Rubinow
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Arch Gen Psychiatry, February 1, 2005; 62(2): 154 - 162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Blouin, S. Blanchette, C. Richard, P. Dupont, V. Luu-The, and A. Tchernof
Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E398 - E404.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Gennari, R. Nuti, and J. P. Bilezikian
Aromatase Activity and Bone Homeostasis in Men
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Leblanc, M.-C. Belanger, P. Julien, A. Tchernof, C. Labrie, A. Belanger, and F. Labrie
Plasma Lipoprotein Profile in the Male Cynomolgus Monkey under Normal, Hypogonadal, and Combined Androgen Blockade Conditions
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1849 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Kuuranne, M. Kurkela, M. Thevis, W. Schanzer, M. Finel, and R. Kostiainen
GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., September 1, 2003; 31(9): 1117 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Leblanc, C. Labrie, A. Belanger, B. Candas, and F. Labrie
Bioavailability and Pharmacokinetics of Dehydroepiandrosterone in the Cynomolgus Monkey
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4293 - 4302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Fassnacht, N. Schlenz, S. B. Schneider, S. A. Wudy, B. Allolio, and W. Arlt
Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2760 - 2766.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Endocr. Rev., April 1, 2003; 24(2): 152 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Lovas, G. Gebre-Medhin, T. S. Trovik, K. J. Fougner, S. Uhlving, B. G. Nedrebo, O. L. Myking, O. Kampe, and E. S. Husebye
Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Health Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1112 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. G. McTernan, L. A. Anderson, A. J. Anwar, M. C. Eggo, J. Crocker, A. H. Barnett, P. M. Stewart, and S. Kumar
Glucocorticoid Regulation of P450 Aromatase Activity in Human Adipose Tissue: Gender and Site Differences
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
E. R. Simpson and M. Dowsett
Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy
Recent Prog. Horm. Res., January 1, 2002; 57(1): 317 - 338.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. R. Simpson and S. R. Davis
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives
Endocrinology, November 1, 2001; 142(11): 4589 - 4594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Arlt, F. Callies, I. Koehler, J. C. van Vlijmen, M. Fassnacht, C. J. Strasburger, M. J. Seibel, D. Huebler, M. Ernst, M. Oettel, et al.
Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4686 - 4692.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
C. Crone, G. Gabriel, and T. N. Wise
Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Psychosomatics, August 1, 2001; 42(4): 285 - 299.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality
PNAS, June 20, 2001; (2001) 121177998.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. R. Simpson and S. R. Davis
Another role highlighted for estrogens in the male: Sexual behavior
PNAS, December 8, 2000; (2000) 11526097.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Barbier, H. Lapointe, M. El Alfy, D. W. Hum, and A. Bélanger
Cellular Localization of Uridine Diphosphoglucuronosyltransferase 2B Enzymes in the Human Prostate by in Situ Hybridization and Immunohistochemistry
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4819 - 4826.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. W. van den Beld, F. H. de Jong, D. E. Grobbee, H. A. P. Pols, and S. W. J. Lamberts
Measures of Bioavailable Serum Testosterone and Estradiol and Their Relationships with Muscle Strength, Bone Density, and Body Composition in Elderly Men
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3276 - 3282.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Albert, O. Barbier, M. Vallee, G. Beaudry, A. Belanger, and D. W. Hum
Distribution of Uridine Diphosphate-Glucuronosyltransferase (UGT) Expression and Activity in Cynomolgus Monkey Tissues: Evidence for Differential Expression of Steroid-Conjugating UGT Enzymes in Steroid Target Tissues
Endocrinology, July 1, 2000; 141(7): 2472 - 2480.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
D. Jarrar, P. Wang, W. G. Cioffi, K. I. Bland, and I. H. Chaudry
Mechanisms of the Salutary Effects of Dehydroepiandrosterone After Trauma-Hemorrhage: Direct or Indirect Effects on Cardiac and Hepatocellular Functions?
Arch Surg, April 1, 2000; 135(4): 416 - 423.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman
Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans
Cancer Res., February 1, 2000; 60(4): 950 - 956.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
E. M Rocha, L A. Wickham, L. A da Silveira, K. L Krenzer, F.-S. Yu, I. Toda, B. D Sullivan, and D. A Sullivan
Identification of androgen receptor protein and 5alpha -reductase mRNA in human ocular tissues
Br. J. Ophthalmol., January 1, 2000; 84(1): 76 - 84.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
G. A. Brown, M. D. Vukovich, R. L. Sharp, T. A. Reifenrath, K. A. Parsons, and D. S. King
Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men
J Appl Physiol, December 1, 1999; 87(6): 2274 - 2283.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
O. Barbier, E. Lévesque, A. Bélanger, and D. W. Hum
UGT2B23, a Novel Uridine Diphosphate-Glucuronosyltransferase Enzyme Expressed in Steroid Target Tissues That Conjugates Androgen and Estrogen Metabolites
Endocrinology, December 1, 1999; 140(12): 5538 - 5548.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Gingras and J. Simard
Induction of 3{beta}-Hydroxysteroid Dehydrogenase/ Isomerase Type 1 Expression by Interleukin-4 in Human Normal Prostate Epithelial Cells, Immortalized Keratinocytes, Colon, and Cervix Cancer Cell Lines
Endocrinology, October 1, 1999; 140(10): 4573 - 4584.
[Abstract] [Full Text]


Home page
NEJMHome page
W. Arlt, F. Callies, J. C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier, D. Huebler, M. Oettel, M. Ernst, H. M. Schulte, et al.
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
N. Engl. J. Med., September 30, 1999; 341(14): 1013 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. J. Rosen
Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications
Clin. Chem., August 1, 1999; 45(8): 1384 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Arlt, J. Haas, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio
Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2170 - 2176.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pritchard, J.-P. Després, J. Gagnon, A. Tchernof, A. Nadeau, A. Tremblay, and C. Bouchard
Plasma Adrenal, Gonadal, and Conjugated Steroids before and after Long Term Overfeeding in Identical Twins
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3277 - 3284.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Arlt, H.-G. Justl, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio
Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1928 - 1934.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. R. Simpson and S. R. Davis
Another role highlighted for estrogens in the male: Sexual behavior
PNAS, December 19, 2000; 97(26): 14038 - 14040.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality
PNAS, July 3, 2001; 98(14): 8145 - 8150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society